BACKGROUND: Sick neonates frequently develop severe thrombocytopenia. OBJECTIVE AND METHODS: In order to test the ability of fetal mice to increase their megakaryocyte size and ploidy in response to thrombocytopenia, we injected an antiplatelet antibody (MWReg30) into pregnant mice daily for 7 days, and into nonpregnant adult mice to serve as controls. After that time, platelet counts were obtained and megakaryocytes in the bone marrow, liver, and spleen were stained with anti-von Willebrand factor antibody, individually measured, and quantified. RESULTS: Our study demonstrated that megakaryocytopoiesis in newborn mice shares many features of human fetal/neonatal megakaryocytopoiesis, including the small size of megakaryocytes. In response to thrombocytopenia, adult mice increased megakaryocyte volume and concentration, primarily in the spleen. Newborn mice, in contrast, increased the megakaryocyte concentration in the spleen, but exhibited no increase in megakaryocyte volume in any of the organs studied. In fact, the megakaryocyte mass was significantly lower in the bone marrow of thrombocytopenic neonates than in age-matched controls. CONCLUSIONS: We concluded that fetuses have a limited ability to increase their megakaryocyte mass in response to consumptive thrombocytopenia, compared to adult mice. These observations provide further evidence for the existence of biological differences between fetal/neonatal and adult megakaryocytopoiesis.
BACKGROUND: Sick neonates frequently develop severe thrombocytopenia. OBJECTIVE AND METHODS: In order to test the ability of fetal mice to increase their megakaryocyte size and ploidy in response to thrombocytopenia, we injected an antiplatelet antibody (MWReg30) into pregnant mice daily for 7 days, and into nonpregnant adult mice to serve as controls. After that time, platelet counts were obtained and megakaryocytes in the bone marrow, liver, and spleen were stained with anti-von Willebrand factor antibody, individually measured, and quantified. RESULTS: Our study demonstrated that megakaryocytopoiesis in newborn mice shares many features of human fetal/neonatal megakaryocytopoiesis, including the small size of megakaryocytes. In response to thrombocytopenia, adult mice increased megakaryocyte volume and concentration, primarily in the spleen. Newborn mice, in contrast, increased the megakaryocyte concentration in the spleen, but exhibited no increase in megakaryocyte volume in any of the organs studied. In fact, the megakaryocyte mass was significantly lower in the bone marrow of thrombocytopenic neonates than in age-matched controls. CONCLUSIONS: We concluded that fetuses have a limited ability to increase their megakaryocyte mass in response to consumptive thrombocytopenia, compared to adult mice. These observations provide further evidence for the existence of biological differences between fetal/neonatal and adult megakaryocytopoiesis.
Authors: K A Ritchie; A A Aprikyan; D F Bowen-Pope; C J Norby-Slycord; S Conyers; S Bartelmez; E H Sitnicka; D D Hickstein Journal: Leukemia Date: 1999-11 Impact factor: 11.528
Authors: J L Teeling; T Jansen-Hendriks; T W Kuijpers; M de Haas; J G van de Winkel; C E Hack; W K Bleeker Journal: Blood Date: 2001-08-15 Impact factor: 22.113
Authors: Pani A Apostolidis; Donna S Woulfe; Massiel Chavez; William M Miller; Eleftherios T Papoutsakis Journal: Exp Hematol Date: 2011-10-21 Impact factor: 3.084
Authors: Viola Lorenz; Haley Ramsey; Zhi-Jian Liu; Joseph Italiano; Karin Hoffmeister; Sihem Bihorel; Donald Mager; Zhongbo Hu; William B Slayton; Benjamin T Kile; Martha Sola-Visner; Francisca Ferrer-Marin Journal: Thromb Haemost Date: 2017-12-06 Impact factor: 5.249
Authors: Zhi-Jian Liu; Karin M Hoffmeister; Zhongbo Hu; Donald E Mager; Sihem Ait-Oudhia; Marlyse A Debrincat; Irina Pleines; Emma C Josefsson; Benjamin T Kile; Joseph Italiano; Haley Ramsey; Renata Grozovsky; Peter Veng-Pedersen; Chaitanya Chavda; Martha Sola-Visner Journal: Blood Date: 2014-03-05 Impact factor: 22.113